PRESCRIBE DIALITY Trademark
Trademark Overview
On Friday, October 20, 2023, a trademark application was filed for PRESCRIBE DIALITY with the United States Patent and Trademark Office. The USPTO has given the PRESCRIBE DIALITY trademark a serial number of 98233972. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Saturday, May 31, 2025. This trademark is owned by Diality Inc.. The PRESCRIBE DIALITY trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:
Conducting medical studies in the field of hemodialysis system
Conducting medical studies for research purposes; New product research and development services in the field of medical equipment; conducting medical studies in the nature of medical and scientific research in the field of hemodialysis; Development of new products in the field of hemodialysis
General Information
| Serial Number | 98233972 |
| Word Mark | PRESCRIBE DIALITY |
| Filing Date | Friday, October 20, 2023 |
| Status | 731 - SECOND EXTENSION - GRANTED |
| Status Date | Saturday, May 31, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 2, 2024 |
Trademark Statements
| Goods and Services | Conducting medical studies in the field of hemodialysis system |
| Goods and Services | Conducting medical studies for research purposes; New product research and development services in the field of medical equipment; conducting medical studies in the nature of medical and scientific research in the field of hemodialysis; Development of new products in the field of hemodialysis |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 26, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 26, 2023 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Diality Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Irvine, CA 92618 |
| Party Name | Diality Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Irvine, CA 92618 |
Trademark Events
| Event Date | Event Description |
| Thursday, October 26, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, February 26, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, February 27, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, October 24, 2023 | NEW APPLICATION ENTERED |
| Wednesday, March 13, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, April 2, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, June 4, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, December 3, 2024 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, December 4, 2024 | SOU EXTENSION 1 FILED |
| Wednesday, December 4, 2024 | SOU EXTENSION 1 GRANTED |
| Friday, May 30, 2025 | SOU TEAS EXTENSION RECEIVED |
| Friday, May 30, 2025 | SOU EXTENSION 2 FILED |
| Tuesday, April 2, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Monday, March 3, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Saturday, May 31, 2025 | SOU EXTENSION 2 GRANTED |
| Monday, September 15, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
